Search research articles
Contact Us
Filters
Showing results (11-20 of 105) with videos related to
Page
of 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Christopher J Patterson, Nikhil J Dhinagar, Emma J Gleave, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Association between psychotropic drug use and heart failure therapy in elderly long-term care residents
George A Heckman, Brian Misiaszek, Fatima Merali, et al.
The Canadian Journal of Cardiology
|
March 19, 2005
Digoxin prescribing for heart failure in elderly residents of long-term care facilities
Brian Misiaszek, George A Heckman, Fatima Merali, et al.
The Canadian Journal of Cardiology
|
August 28, 2004
Management of heart failure in Canadian long-term care facilities
George A Heckman, Brian Misiaszek, Fatima Merali, et al.
Blood
|
May 14, 2011
Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab
Steven P Treon, Jacob D Soumerai, Zachary R Hunter, et al.
British Journal of Haematology
|
May 28, 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen
Steven P Treon, Christina Hanzis, Robert J Manning, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 26, 2013
Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration
Steven P Treon, Christina K Tripsas, Bryan T Ciccarelli, et al.
Clinical Lymphoma & Myeloma
|
April 14, 2009
Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia
Leukothea Ioakimidis, Christopher J Patterson, Zachary R Hunter, et al.
Clinical Lymphoma
|
March 30, 2005
CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia
Zachary R Hunter, Andrew R Branagan, Robert Manning, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 23, 2012
Familial disease predisposition impacts treatment outcome in patients with Waldenström macroglobulinemia
Steven P Treon, Christina Tripsas, Christina Hanzis, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 105) with videos related to
Sort By:
Page
of 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Christopher J Patterson, Nikhil J Dhinagar, Emma J Gleave, et al.
Journal of the American Geriatrics Society
|
January 3, 2007
Association between psychotropic drug use and heart failure therapy in elderly long-term care residents
George A Heckman, Brian Misiaszek, Fatima Merali, et al.
The Canadian Journal of Cardiology
|
March 19, 2005
Digoxin prescribing for heart failure in elderly residents of long-term care facilities
Brian Misiaszek, George A Heckman, Fatima Merali, et al.
The Canadian Journal of Cardiology
|
August 28, 2004
Management of heart failure in Canadian long-term care facilities
George A Heckman, Brian Misiaszek, Fatima Merali, et al.
Blood
|
May 14, 2011
Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab
Steven P Treon, Jacob D Soumerai, Zachary R Hunter, et al.
British Journal of Haematology
|
May 28, 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen
Steven P Treon, Christina Hanzis, Robert J Manning, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 26, 2013
Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration
Steven P Treon, Christina K Tripsas, Bryan T Ciccarelli, et al.
Clinical Lymphoma & Myeloma
|
April 14, 2009
Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia
Leukothea Ioakimidis, Christopher J Patterson, Zachary R Hunter, et al.
Clinical Lymphoma
|
March 30, 2005
CD5, CD10, and CD23 expression in Waldenstrom's macroglobulinemia
Zachary R Hunter, Andrew R Branagan, Robert Manning, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 23, 2012
Familial disease predisposition impacts treatment outcome in patients with Waldenström macroglobulinemia
Steven P Treon, Christina Tripsas, Christina Hanzis, et al.
Page
of 11